Management of Patients on Non-Vitamin K Antagonist Oral Anticoagulants in the Acute Care and Periprocedural Setting: A Scientific Statement From the American Heart Association.
about
The safety of edoxaban for treating atrial fibrillation.Idarucizumab for the treatment of hemorrhage and dabigatran reversal in patients requiring urgent surgery or procedures.Practical Implementation of Anticoagulation Strategy for Patients Undergoing Cardioversion of Atrial Fibrillation.Time for Practical Clinical Tools.Position Paper on laboratory testing for patients on direct oral anticoagulants. A Consensus Document from the SISET, FCSA, SIBioC and SIPMeL.The role of direct oral anticoagulants in cancer-related venous thromboembolism: a perspective beyond the guidelines.AHNS Series: Do you know your guidelines? Perioperative antithrombotic management in head and neck surgery.Multidisciplinary approach to cardiac and pulmonary vascular disease risk assessment in liver transplantation: An evaluation of the evidence and consensus recommendations.Dabigatran level monitoring prior to idarucizumab administration in patients requiring emergent cardiac surgery.Andexanet alfa effectively reverses edoxaban anticoagulation effects and associated bleeding in a rabbit acute hemorrhage model.New Trends in Anticoagulation Therapy.Periprocedural anticoagulation in atrial fibrillation: Update on electrical cardioversion and ablation.Minor Plasma Lipids Modulate Clotting Factor Activities and May Affect Thrombosis Risk.Edoxaban Management in Diagnostic and Therapeutic Procedures (EMIT-AF/VTE) - Trial DesignReversal Strategies for Intracranial Hemorrhage Related to Direct Oral Anticoagulant Medications
P2860
Q38598266-0739709C-C148-4DAA-B07C-D4839606A295Q39448172-2E6D7638-A442-4D77-BE23-7477D6A3D39AQ41061213-EBEDE362-83A9-4681-AEED-92A67D56CD3BQ42363087-84C22C53-9457-46F8-914B-DF708B057EB4Q45874001-C13521B1-5A2F-4D4C-96D9-FBF9446E7772Q47393865-746F4D41-8E06-49B8-96F9-58D22F6C5752Q47769344-ACFDEF15-119C-46FA-9667-F117E0E49C96Q47912085-E230BBB0-9142-4386-8247-9473AEC844FDQ48149529-9CCDBE3E-0AC1-4E56-B32A-D4DF38D0EBDEQ52625566-F2A5D06E-7FDB-4E30-A05F-8DC32D3C5DFFQ52675244-402A699B-114E-4753-9BE5-CD45382D1B24Q55055702-514DBC88-E9A5-4A1A-BA5D-E78F7F7D739AQ55359034-F693AE33-DFA5-4C83-BF12-DA90FE563741Q56516532-9C4FA954-A0AA-4561-82DB-9B5B690CDF12Q57177164-19ABA712-BC9A-4905-A55E-06B17050DAE8
P2860
Management of Patients on Non-Vitamin K Antagonist Oral Anticoagulants in the Acute Care and Periprocedural Setting: A Scientific Statement From the American Heart Association.
description
2017 nî lūn-bûn
@nan
2017年の論文
@ja
2017年学术文章
@wuu
2017年学术文章
@zh-cn
2017年学术文章
@zh-hans
2017年学术文章
@zh-my
2017年学术文章
@zh-sg
2017年學術文章
@yue
2017年學術文章
@zh
2017年學術文章
@zh-hant
name
Management of Patients on Non- ...... he American Heart Association.
@en
type
label
Management of Patients on Non- ...... he American Heart Association.
@en
prefLabel
Management of Patients on Non- ...... he American Heart Association.
@en
P2093
P2860
P921
P1433
P1476
Management of Patients on Non- ...... he American Heart Association.
@en
P2093
Allyson R Zazulia
American Heart Association Cli ...... of Care and Outcomes Research
Amish N Raval
Babu G Welch
Deborah Diercks
Hee Soo Jung
Jeffrey B Washam
Joaquin E Cigarroa
Larry J Diaz-Sandoval
Mina K Chung
P2860
P304
P356
10.1161/CIR.0000000000000477
P407
P577
2017-02-06T00:00:00Z